Renin inhibitors, such as Aliskiren, offer therapeutic benefits by reducing these adverse effects and improving glycemic control, thereby protecting against T2D-induced kidney and vascular damage [62]. The gene discussed is REN; the disease is type 2 diabetes mellitus.